Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation

The ability of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) to maintain virologic suppression in participants with M184V and/or M184I resistance mutations from historical genotypic reports when switching from a tenofovir disoproxil fumarate–based or abacavir (ABC)-based re...

詳細記述

保存先:
書誌詳細
出版年:J Acquir Immune Defic Syndr
主要な著者: Perez-Valero, Ignacio, Llibre, Josep M., Castagna, Antonella, Pulido, Federico, Molina, Jean-Michel, Esser, Stefan, Margot, Nicolas, Shao, Yongwu, Temme, Lauren, Piontkowsky, David, McNicholl, Ian R., Haubrich, Richard
フォーマット: Artigo
言語:Inglês
出版事項: JAIDS Journal of Acquired Immune Deficiency Syndromes 2021
主題:
Clinical Science
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7899215/
https://ncbi.nlm.nih.gov/pubmed/33315694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002595
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料